Sylvester, Dana-Farber researchers receive $7M from PCORI to study diet, exercise effects on mental and physical functioning in older cancer survivors

Dana-Farber/Harvard Cancer Center awarded $12M NIH SPORE grant to advance breast cancer research

From left to right: Geoffrey Shapiro, Leif Ellisen and Nancy Lin. Sitting below them is Kornelia Polyak.The Dana-Farber/Harvard Cancer Center, a cancer research consortium comprised of five of Boston’s academic medical centers, including Dana-Farber Cancer Institute and Massachusetts General Hospital, has been awarded an NCI grant to continue its Specialized Program of Research Excellence in Breast Cancer.

October 03, 2025

Vol.51 No.36

Ci4CC’s 24th Symposium & Workshop set to focus on precision oncology powered by data intelligence

Chaired by the University of Miami Sylvester Comprehensive Cancer Center, the 24th Cancer Centers Informatics Society (Ci4CC) Symposium will convene the nation’s leading designated and community cancer centers with a central focus on advancing precision oncology.

Mammograms may benefit women well into their 80s, UCLA study finds

For many older women, the question of whether to continue breast cancer screening has been uncertain. While most guidelines recommend mammograms up to age 74, advice for women 75 and older has been less clear.

September 26, 2025

Vol.51 No.35

Clinical Roundup

Korean researchers find CRC patients over 70 years don’t stand to benefit from chemo

Oxaliplatin-based chemotherapy significantly improves survival only in stage 3 colorectal cancer patients aged 70 or younger, according to a study conducted by researchers at Korea University Guro Hospital and Korea University College of Medicine. For patients over 70, the drug offered no survival advantage and led to higher rates of treatment discontinuation due to toxicity.

September 26, 2025

Vol.51 No.35

Clinical Roundup

Cyclin A/B RxL inhibitors restore G1–S-checkpoint in treatment of small cell lung cancer, DFCI research shows

A new class of drug results in cancer cell death in cancers, such as small cell lung cancer, with a disabled quality control cell cycle checkpoint known as the G1/S checkpoint, according to research gathered by the Oser Lab at Dana-Farber Cancer Institute.

September 12, 2025

Vol.51 No.33

In Brief

VCU Massey awards first $50,000 harvest grant to Free Clinic of Powhatan

Officials from VCU Massey Comprehensive Cancer Center awarded the center’s first $50,000 harvest grant to the Free Clinic of Powhatan, extending a commitment to the clinic’s “Eat Well, Be Well,” pilot nutrition program.

July 18, 2025

Vol.51 No.28

Sylvester, Dana-Farber researchers receive $7M from PCORI to study diet, exercise effects on mental and physical functioning in older cancer survivors

YOU MAY BE INTERESTED IN

Dana-Farber/Harvard Cancer Center awarded $12M NIH SPORE grant to advance breast cancer research

Ci4CC’s 24th Symposium & Workshop set to focus on precision oncology powered by data intelligence

Mammograms may benefit women well into their 80s, UCLA study finds

Korean researchers find CRC patients over 70 years don’t stand to benefit from chemo

Cyclin A/B RxL inhibitors restore G1–S-checkpoint in treatment of small cell lung cancer, DFCI research shows

VCU Massey awards first $50,000 harvest grant to Free Clinic of Powhatan

Renew today!

Subscriber content

Never miss an issue!

Login